Concord Biotech Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
329.78
248.98
270.47
201.48
284.79
Other Income Qtr Cr10.818.198.136.6512.20
Operating Revenues Qtr318.97240.80262.35194.83272.59

*All values are in Cr.

Operating Expenses Qtr
184.68
134.87
143.16
122.68
143.52
Operating Profit Qtr
134.29
105.93
119.19
72.15
129.06
EBIDT Qtr Cr
145.10
114.12
127.32
78.81
141.26
Depreciation Qtr
13.72
13.54
13.30
13.04
14.18
Net Profit Qtr
95.02
77.57
81.02
54.49
91.49
Basic EPS Qtr
9.08
7.41
7.74
5.21
8.75
Open Demat Account
+91 -

personImage